How pharma could shift from curing disease to promoting healthy ageing through epigenetics, the microbiome and antimicrobial ...

Uncertainty surrounding US tariffs and global economic headwinds has tempered hiring in India's pharma and healthcare GCCs.

Donald Trump's healthcare revamp, emphasizing generics and biosimilars, could boost Indian drug makers, who already supply 40 ...

To receive daily news and insights ... Although the uncertainty took a bite out of Big Pharma stocks, the industry was mostly spared from the worst of the upheaval. “The Trump administration ...

Meanwhile, in Ireland, sentiment had been positive that its Pharma industry, an invaluable source ... is a 15-20 year process, perhaps even a >50-year one. If President Trump goes ahead and ...